## **Core Concept**
Cyclosporin-A is an immunosuppressive medication primarily used to prevent organ rejection in transplant patients. It works by inhibiting the immune response, specifically by affecting T-lymphocytes. The drug's mechanism involves binding to cyclophilin, a protein in T-cells.

## **Why the Correct Answer is Right**
Cyclosporin-A exerts its immunosuppressive effects by forming a complex with cyclophilin (a cytosolic protein), which then inhibits **calcineurin**, a phosphatase enzyme crucial for the activation of T-lymphocytes. By inhibiting calcineurin, Cyclosporin-A prevents the transcription of the interleukin-2 (IL-2) gene, which is essential for T-cell proliferation and activation. This action primarily occurs at the level of T-lymphocytes, making **Cyclophilin** the correct target.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While cyclosporin-A does have effects downstream that can influence various cellular processes, saying it acts on "Calcineurin" directly might be misleading because it acts by forming a complex with cyclophilin that then inhibits calcineurin.
- **Option B:** "Interleukin-2 receptor" is not the direct target; rather, cyclosporin-A prevents the production of IL-2.
- **Option D:** "Complement C3" is not directly involved in the mechanism of action of cyclosporin-A. Cyclosporin-A's action is more specific to T-cell activation.

## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that the use of cyclosporin-A can lead to nephrotoxicity and hypertension as side effects, likely due to its vasoconstrictive effects on renal vessels and possibly direct toxic effects on renal tubules. Monitoring renal function and blood pressure is crucial in patients on this medication.

## **Correct Answer:** . Cyclophilin